首页> 外文会议>IEEE Signal Processing in Medicine and Biology Symposium >Decision quality support in diagnostic breast ultrasound through artificial Intelligence
【24h】

Decision quality support in diagnostic breast ultrasound through artificial Intelligence

机译:通过人工智能诊断乳房超声中的决策质量支持

获取原文

摘要

Medical Ultrasonography is a valuable imaging technology for medical diagnostics and, more recently, as a screening alternative to mammography for women with dense breasts. However, ultrasound imaging within the contexts of both diagnostic and screening mammography suffers from inter-operator and intra-operator variability. Consequently, there is a broad distribution of performance profiles, even for radiologists of similar training. Typically, these profiles tend to err on the side of caution, preferring false positive errors to false negative errors. While this approach may lead to a higher Cancer Detection Rate (CDR), it also lowers the Positive Predictive Value (PPV3) of performed biopsies. A lower PPV3 translates to an increase in benign biopsies, the annual cost of which are estimated to be on the order of 1?3 billion USD (not including pathological workups). And, of course, there is the immeasurable cost of pain, worry, and suffering borne by women undergoing these potentially unnecessary procedures. In this paper, we evaluate the ability of the ClearView cCAD algorithms to increase overall performance and reduce the inter-operator variance on a set of imaged lesions. The cCAD system provides an automated assessment of some ACR BI-RADs criteria and calculates a preliminary BI-RADs assessment, given as BI-RADS categorical bucket (1-3) or (4-5). Through the evaluation of 1300 breast lesion images, 3 MQSA certified radiologists were asked to determine both a Likelihood of Malignancy (LoM) and a BI-RADs assessment, from which their ROC curve AUC as well as PPV3 could be calculated. The cCAD system was also evaluated, on the same set of lesions, by a similar set of metrics. From this analysis we have been able to show that the cCAD system outperforms radiologists at all operating points within the scope of this study design. Furthermore, we've shown that through simple fusion schemes we are able to increase performance beyond that of either the cCAD system or the radiologist alone by all typically tracked quality metrics, and significantly reduce inter-operator variance.
机译:医疗超声检查是医疗诊断的有价值的成像技术,并且最近是乳房X线摄影乳腺癌的筛选替代品。然而,在诊断和筛选乳房X线摄影的上下文中的超声成像遭受操作间和操作员的帧内变化。因此,即使对于类似训练的放射科学家,也存在具有广泛的性能型材分布。通常,这些型材倾向于在谨慎的一侧误差,更倾向于对假阴性误差的假阳性误差。虽然这种方法可能导致较高的癌症检测率(CDR),但它也降低了进行的活组织检查的阳性预测值(PPV3)。较低的PPV3转化为良性活检的增加,其年度成本估计约为1?30亿美元(不包括病理次数)。而且,当然,由于经历这些可能不必要的程序,患有不可估量的痛苦,担忧和痛苦的痛苦成本。在本文中,我们评估了ClearView CCAD算法的能力,提高了整体性能,并降低了一组成像病变上的操作互操作范围。 CCAD系统提供了一些ACR BI-RADS标准的自动评估,并计算为Bi-Rads分类桶(1-3)或(4-5)给出的初步BI-RADS评估。通过评估1300个乳房病变图像,要求3个MQSA认证放射科医师确定恶性肿瘤(LOM)和BI-RADS评估的可能性,从中可以计算其ROC曲线AUC以及PPV3。 CCAD系统也通过类似的度量集评估。从这个分析来看,我们已经能够表明CCAD系统在本研究设计范围内的所有运营点都优于放射科医师。此外,我们已经表明,通过简单的融合方案,我们能够通过所有通常跟踪的质量指标单独提高CCAD系统或放射科医生的性能,并显着降低算子间方差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号